Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atenolol vs Ivabradine for Clozapine-Induced Tachycardia
NCT06505668Recruiting
- Sponsor
- AIIMS New Delhi
- Start
- Aug 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ivabradine in tachycardia (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Changes in the Frequency domain of Heart Rate Variability at 2 months. Started Aug 2023; status: recruiting.
02
Drugs
ivabradine
03
Conditions
tachycardia
Beyond the preview
Go deeper on NCT06505668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06505668.